Alzheimer's Disease Research Center (ADRC), University of Washington
Please read our COVID-19 Update for ADRC research participants
The UW Alzheimer’s Disease Research Center (ADRC) is one of a nationwide network of 30 research resource centers funded by the National Institute on Aging. ADRCs are major sources of discovery into the nature of Alzheimer’s disease and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. The UW ADRC contributes to the development of shared resources that support dementia-relevant research, and coordinates research efforts with other NIH-funded programs and investigators. UW ADRC resources are designed to facilitate and empower related research efforts at UW.
The UW ADRC is closely affiliated with the UW Memory and Brain Wellness Center clinic and links the Seattle community with information and opportunities to participate in studies of Alzheimer’s disease and related disorders (Lewy body dementia, and frontotemporal degeneration, and vascular dementia). Our busy outreach team is influential in promoting strengths-based reframing of Alzheimer’s disease and dementia-friendly communities, and they organize and promote educational public talks and events and research seminars. We support outreach and culturally adapted Alzheimer’s disease programs for Indigenous communities and clinics. Join us!
September 30, 2022 — Read the latest edition of our monthly newsletter
July 29, 2022 — The UW ADRC offers one-year development projects that use its resources to advance the understanding, diagnosis, and/or treatment of Alzheimer’s disease. In the 2023-2024 period, the UW ADRC aims to fund 3-4 projects of up to $50,000. At least two awards will be reserved for junior applications (Postdoctoral fellows with appropriate senior collaborators or junior faculty up to the rank of Assistant Professor). Please see click the link for eligibility details and key dates, and disseminate widely.
July 28, 2022 — The UW ADRC is excited about the official launch of the Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD) web product (SEA-AD.org) and the first public release of the project’s data. This release is an important new resource for the Alzheimer’s community. The SEA-AD is a NIA-funded collaboration between the Allen Brain Institute, UW Medicine, and Kaiser Permanente Health Research Institute to create a higher resolution atlas of Alzheimer’s disease at the cellular level, in order to understand the early pathogenesis of AD, disease initiation, and cognitive decline.
April 14, 2022 — "WRF’s generous support has enabled us to make rapid progress on early-stage drug discovery work towards MSUT2-based therapeutics." - UW ADRC's Brian Kraemer, PhD
Upcoming Research Events
Medical Update on Normal Aging, MCI, and Dementia: Dementia Support NW's Planning for Dementia, A Rainbow of Choices: Session 1
Friday, October 7, 2022 1:30pm - 2:30pm
MBWC's Dr. Kris Rhoads will review both age-related and pathological changes in cognition occurring in older adult populations, including mild cognitive impairment, Alzheimer's disease, and related disorders with a focus on health and health care disparities and populations at increased risk for cognitive impairment.
Saturday, October 8, 2022 12:00pm - 1:00pm
The Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) and the Alzheimer’s Association are pleased to announce the 2022 Early-Onset Dementia Family Conference for patients, families and caregivers impacted by early-onset dementia. The conference will be held virtually on Saturday and Sunday, October 8 and 9th 2022 from 8am-12:00pm PT on each day. It will offer attendees information and opportunities to share insights and experiences with each other as well as with researchers in the field. On the second day of the conference, care and support will be provided to any interested participants.
Monday, October 10, 2022 12:00pm - 1:00pm
Title: Proteomic signatures associated with rate of cognitive decline in genetically-defined risk groups